Thromboembolic events associated with immune checkpoint inhibitors: A real-world study of data from the food and drug administration adverse event reporting system (FAERS) database-Reference-Cited by-同舟云学术

Thromboembolic events associated with immune checkpoint inhibitors: A real-world study of data from the food and drug administration adverse event reporting system (FAERS) database

Published:2021-09 Issue: Volume:98 Page:107818
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Hao,Sun Ximu,Sun Dan,Zhao Jin,Xu Zhouming,Zhao Peng,Ma Zhuo,Zhang Yuhui

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. Immune checkpoint blockade in cancer therapy;Postow;J. Clin. Oncol.,2015

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. Thompson, A. John, New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity. Journal of the National Comprehensive Cancer Network, 2018. 16(5S): p. 594-596.

4. L. Kennedy, A. Salama, A review of cancer immunotherapy toxicity, CA: A Cancer J. Clin., 2020. 70(2): p. 86-104.

5. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs causing prostate-specific antigen changes: the food and drug administration adverse event reporting system combined with Mendelian randomization analysis;Expert Opinion on Drug Safety;2024-09-14

2. Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database;Frontiers in Pharmacology;2024-09-02

3. Drugs Associated with Urinary Retention Adverse Reactions: A Joint Analysis of FDA Adverse Event Reporting System and Mendelian Randomization;Urology;2024-08

4. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase;eClinicalMedicine;2024-07

5. Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system;Frontiers in Immunology;2024-04-30